Feb 08,2022

Abbott Announces Partnerships with 1MG, PharmEeasy and 7 Other in India

Abbott, a global healthcare leader, has partnered with key health-tech firms including BeatO, Sugar.fit, PharmEasy, GOQii, 1MG, Zyla Health, Healthifyme and Fitterfly to usher in a new era of holistic diabetes management care. Through these collaborations, Abbott aims to offer glucose monitoring solutions to 8 million people living with diabetes, of which approximately 6.5 million users can access through PharmEasy and 1MG. The company is focused on maintaining effective glucose level along with remote consultations, diabetes-specific coaching, and dietary plans.
 

COLLABORATION PARTNERSHIP

#institution

#cgm

View Analyst & Ambassador Comments
Go to original news
May 12,2019

VA and Virta Health partner in innovative approach to diabetes care

The U.S. Department of Veterans Affairs (VA) announced a partnership on May 13 with Virta Health to explore an innovative program focused on improving the health of persons with type 2 diabetes. In effect since March 22, the agreement will give 400 Veterans the opportunity to participate in the Virta Treatment, which can help individuals safely and sustainably achieve glycemic control while reducing use of medications. This diabetes care will be provided for up to one year at no cost to VA or Veteran participants.

COLLABORATION PARTNERSHIP

#institution

#virtual care

View Analyst & Ambassador Comments
Go to original news
Jul 20,2021

Aidence and Heart&Lung partner for Greater Manchester cancer screening

Medtech firm Aidence and Heart&Lung Health (H&L), a specialist in chest and cardiac radiology reporting, have partnered to provide AI-powered, scan reporting for lung cancer screening in Tameside, Glossop, and North Manchester Clinical Commission Groups (CCGs). The collaboration between Manchester University NHS Foundation Trust (MFT), Aidence, and H&L aims to ensure that no early-stage cancers are missed in the screening chest CT scans and that reporting follows the correct protocol and the highest clinical standards.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Apr 07,2021

Aidence partners with the Netherlands Cancer Institute to leverage AI for lung cancer care

The Netherlands Cancer Institute (NKI), one of the world’s top 10 comprehensive cancer centres, is using artificial intelligence (AI) for lung nodule management. The AI solution, Veye Lung Nodules, is provided by MedTech scaleup Aidence. Veye Lung Nodules is a CE certified second or concurrent reader used in routine practice and lung cancer screening across Europe. At NKI, it will analyse over 15,000 chest CT scans per year, and the additional prior scans for approximately 80% of studies.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Dec 04,2019

Affidea partners with Aidence in lung cancer screening and diagnosis

As the leading European provider of advanced diagnostic imaging services, Affidea is starting the collaboration with Aidence, a medical artificial intelligence (AI) company that develops deep-learning solutions for healthcare, by implementing its AI solution Veye Lung Nodules on a ground-breaking pilot in three countries: Italy, Greece, and Hungary, with the possibility to extend it to other regions across Affidea’s European network.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Dec 19,2022

The Postgraduate Institute for Medicine and VieCure Announce a Partnership to Provide CME to Users of the VieCure Platform through Internet Search and Learn

The Postgraduate Institute for Medicine (PIM), which accredits more than 2,500 educational activities for healthcare professionals each year, and VieCure, a cancer care company with a powerful clinical decision support platform, are pleased to announce a new partnership designed to offer continuing medical education (CME) to the multidisciplinary cancer care teams utilizing the VieCure platform. Beginning in January 2023, VieCure users will be eligible to earn 0.5 AMA PRA Category 1 Credit™ for each internet search and learn session they perform.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jan 18,2023

VieCure Aligns with Oncology Care Partners to Accelerate the Adoption of Value-Based Cancer Care

VieCure today announced a new strategic partnership with value-based care organization, Oncology Care Partners (“OCP”), which will assist OCP in its provision of world- class care to patients across its growing U.S. network. This collaboration will support OCP’s providers in creating personalized treatment plans using VieCure’s Halo Intelligence Platform and help OCP to advance its commitment to overall health equity for the patients that they serve.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Aug 21,2022

The Oncology Institute Partners with Blue Note Therapeutics to Provide a Digital Therapeutic for Treating Cancer-related Anxiety and Depression Symptoms

The Oncology Institute, Inc., one of the largest value-based community oncology groups in the United States, and Blue Note Therapeutics, a prescription digital therapeutics (PDT) company dedicated to easing the burden of cancer and improving outcomes, have partnered to provide enhanced psychological support services for TOI patients. Blue Note’s cancer-specific prescription digital therapeutic attune™ is the first digital therapeutic designed to treat anxiety and depression symptoms related to cancer. Attune will be available to all eligible TOI patients by prescription.

COLLABORATION PARTNERSHIP

#institution

#dtx

View Analyst & Ambassador Comments
Go to original news
Dec 13,2022

PatientsLikeMe Partners with LetsGetChecked to Offer Members Access to Home Testing Solutions

PatientsLikeMe (PLM), the trusted community health network that empowers patients to take charge of their health, announced today its partnership with LetsGetChecked, a global healthcare solutions company. The partnership will provide PLM’s 1 million members with access to enhanced patient support capabilities for testing. PLM’s expansive patient community can now utilize LetsGetChecked’s suite of offerings directly through the PLM platform and receive a discount on screening tests for being a PLM member.

COLLABORATION PARTNERSHIP

#institution

#platform

View Analyst & Ambassador Comments
Go to original news
Feb 13,2023

Johnson & Johnson MedTech India Partners With Karkinos To Upskill Healthcare Professionals In Cancer Care

 To make quality cancer treatment accessible and affordable for everyone, Johnson & Johnson MedTech India is joining hands with Karkinos Healthcare, an end-to-end technology platform, to pursue opportunities in upskilling healthcare professionals in cancer care. To bridge the gap, Johnson & Johnson has been investing in upskilling surgeons through its physical and mobile institutes, and tie-ups with Centers of Excellence. The Johnson & Johnson Institute currently offers more than 225 online assets in 25 curriculums, covering 11 surgical specialties. Surgeons enjoy a connected experience through new age learning formats like artificial intelligence, virtual reality, and telemedicine. The partnership aims to combine this digital learning methodology with Karkinos’ expertise of enabling hospitals in setting up comprehensive cancer care systems.

COLLABORATION PARTNERSHIP

#institution

#ai/software

#platform

View Analyst & Ambassador Comments
Go to original news
Subscribe to INSTITUTION